Abstract
The novel compound 2-{[4-(4-bromophenyl)piperazin-1-yl)]methyl}-4-(3-chlorophenyl-5-(4-methoxyphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione is obtained in good yield via a three-step protocol. The product’s structure is assigned by HRMS, IR, 1H and 13C NMR experiments.
Subject
Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry
Reference35 articles.
1. New phenolic Mannich bases with piperazines and their bioactivities;Gul;Bioorg. Chem.,2019
2. Synthesis and anticancer evaluation of 2-oxo-2-(arylamino)-ethyl 4- phenylpiperazine-1-carbodithioates;Hafeez;Pak. J. Pharm. Sci.,2021
3. Synthesis, anticancer activity and molecular docking studies of new 4-nitroimidazole derivatives;Alhelal;Arkivoc,2021
4. Zárate, A.M., Espinosa-Bustos, C., Guerrero, S., Fierro, A., Oyarzún-Ampuero, F., Quest, A.F.G., Di Marcotullio, L., Loricchio, E., Caimano, M., and Calcaterra, A. (2021). A New Smoothened Antagonist Bearing the Purine Scaffold Shows Antitumour Activity In Vitro and In Vivo. Int. J. Mol. Sci., 22.
5. Synthesis of Novel Amide Functionalized Pyrido[2,3-d]pyrimidine Derivatives and their Anticancer Activity;Abba;Asian J. Chem.,2021